#Pharma #Semaglutide #Healthcare #HospitalPharmacy #Pharmacy #IndianPharma #DiabetesCare To view or add a comment, sign in Today marks an inflection point in Indian Pharma history as the most talked about drug, #semaglutide loses its patent protection
Composition Each vial is represented as an 80mg blend: 50mg GHK-Cu, 10mg KPV, 10mg TB-500, and 10mg BPC-157
Studies have shown measurable bone density changes in as little as 12 months of treatment
Cost differences matter: generic or compounded Semaglutide may be cheaper
9 Many of these patients are currently using or will eventually use GLP-1 RAs
NielsenIQ segments new consumers who have started taking the medication in the latest 1-3 months, 4-6 months, and 7-11 months, and interestingly, in the latest 1-3 month data set, the newest users index even younger